VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
0.6300
+0.0054 (0.86%)
At close: Mar 20, 2026, 4:00 PM EDT
0.6219
-0.0081 (-1.29%)
After-hours: Mar 20, 2026, 7:50 PM EDT
VYNE Therapeutics Market Cap
VYNE Therapeutics has a market cap or net worth of $20.82 million as of March 20, 2026. Its market cap has decreased by -41.26% in one year.
Market Cap
20.82M
Enterprise Value
-8.19M
1-Year Change
-41.26%
Ranking
Category
Stock Price
$0.63
Market Cap Chart
Since March 10, 2020, VYNE Therapeutics's market cap has decreased from $229.74M to $20.82M, a decrease of -90.94%. That is a compound annual growth rate of -32.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 20.99M | 8.72% |
| Dec 31, 2025 | 19.31M | -60.93% |
| Dec 31, 2024 | 49.42M | 51.96% |
| Dec 29, 2023 | 32.52M | 273.57% |
| Dec 30, 2022 | 8.71M | -84.05% |
| Dec 31, 2021 | 54.59M | -79.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Longeveron | 23.06M |
| Marker Therapeutics | 22.34M |
| NanoViricides | 22.24M |
| Skye Bioscience | 21.66M |
| Daré Bioscience | 19.43M |
| IN8bio | 19.35M |
| Pasithea Therapeutics | 18.40M |
| Lexaria Bioscience | 17.75M |